1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Atossa Therapeutics Inc (ATOS)

  7. Atossa Therapeutics Inc (ATOS) News

ATOS

Atossa Therapeutics Inc
0.6766
-0.0027 (-0.4%)
Upgrade to Real-Time
Stock Name Stock Symbol Market Stock Type
Atossa Therapeutics Inc ATOS NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
Upgrade Icon
-0.0027 -0.4% 0.6766 10:45:58
Open Price Low Price High Price Close Price Previous Close
0.71 0.671 0.71 0.6964 0.6793
more quote information »

Recent News

Date Time Source Heading
23/3/202307:06EDGARCurrent Report Filing (8-k)
23/3/202307:05GLOBEAtossa Therapeutics Announces Year-End 2022 Financial..
22/3/202304:19PRNUSAtossa Therapeutics and Quantum Leap Healthcare Announce New..
22/3/202300:15GLOBEAtossa Therapeutics and Quantum Leap Healthcare Announce New..
16/3/202300:25GLOBEAtossa to Present at the Sidoti Small-Cap Virtual Conference
14/3/202300:13EDGARCurrent Report Filing (8-k)
07/3/202308:16EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202308:11EDGARStatement of Changes in Beneficial Ownership (4)
24/2/202301:15GLOBEAtossa Doses First Patient in Phase 2 Neoadjuvant Clinical..
14/2/202301:15GLOBEAtossa Therapeutics Further Strengthens Intellectual..
10/2/202303:13EDGARAmended Statement of Ownership (sc 13g/a)
26/1/202301:15GLOBEAtossa Therapeutics Issues Letter to Shareholders
08/12/202200:00GLOBEAtossa Therapeutics Announces the Appointment of Eric Van..
08/11/202208:07EDGARQuarterly Report (10-q)
08/11/202208:01EDGARCurrent Report Filing (8-k)
08/11/202208:00GLOBEAtossa Therapeutics Announces Third Quarter 2022 Financial..
02/11/202200:15GLOBEAtossa Therapeutics, Inc. to Acquire Stake in Privately Held..
26/10/202200:15GLOBEAtossa Therapeutics, Inc. Announces Appointment of Pharma..
25/10/202200:15GLOBEAtossa Therapeutics, Inc. Receives Authorization from FDA to..
08/10/202207:16EDGARCurrent Report Filing (8-k)
07/9/202223:00GLOBEAtossa Therapeutics, Inc. to Attend the 24th Annual H.C...
22/8/202223:30GLOBERegistration Now Open for Tribe Public’s Webinar Event "The..
18/8/202223:30GLOBEAtossa Therapeutics Appoints Dr. Paul Wabnitz to Its..
09/8/202206:30GLOBEAtossa Therapeutics Announces Second Quarter 2022 Financial..
09/8/202206:01EDGARCurrent Report Filing (8-k)
30/7/202202:05TRMNMaxim Group Thinks Atossa Therapeutics’ Stock is Going to..
28/7/202223:00GLOBEDosing Completed in Part C of Atossa’s Phase 1/2a Study of..
14/7/202208:56TRMNAtossa: Acquiring CAR-T Company Would Be a Great Move, Says..
12/7/202221:35TRMNMaxim Group Thinks Atossa Therapeutics’ Stock is Going to..
09/7/202207:00EDGARStatement of Ownership (sc 13g)
03/6/202206:05GLOBEAtossa Therapeutics Appoints Biotech Industry Communications..
18/5/202223:30GLOBEAtossa Therapeutics to Present at the H.C. Wainwright Global..
17/5/202208:24EDGARStatement of Changes in Beneficial Ownership (4)
16/5/202223:03EDGARCurrent Report Filing (8-k)
10/5/202206:10EDGARQuarterly Report (10-q)
10/5/202206:05GLOBEAtossa Therapeutics Announces First Quarter 2022 Financial..
10/5/202206:02EDGARCurrent Report Filing (8-k)
27/4/202223:30GLOBEAtossa Therapeutics to Present at the Q2 Investor Summit..
20/4/202223:30GLOBEAtossa Therapeutics Announces Completion of Part B of..
12/4/202206:06EDGARProxy Statement (definitive) (def 14a)
02/4/202207:02EDGARProxy Statement - Notice of Shareholders Meeting..
Your Recent History
NASDAQ
ATOS
Atossa The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230325 03:55:03